<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859491</url>
  </required_header>
  <id_info>
    <org_study_id>MCAs and Short-Term Recovery</org_study_id>
    <nct_id>NCT04859491</nct_id>
  </id_info>
  <brief_title>Effect of Carbohydrate-protein Co-ingestion on Short-term Recovery</brief_title>
  <official_title>Effects of Post-Exercise Recovery Drink Composition on Subsequent Performance in Masters Class Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erica Goldstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Central Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the consumption of a carbohydrate,&#xD;
      carbohydrate plus protein, or placebo sports drink during a 2-hour recovery period&#xD;
      effectively moderates performance decrements during a subsequent bout of high-intensity&#xD;
      exercise. This information will benefit any endurance-trained masters class athlete who may&#xD;
      need to compete or train multiple times a day.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To test the hypothesis, this study will utilize a randomized, double-blind,&#xD;
      placebo-controlled between-subject design to examine the effects of carbohydrate (CHO) and&#xD;
      carbohydrate-protein (CHO-P) supplementation on short-term recovery following aerobic&#xD;
      interval exercise (INT) and time to exhaustion (TTE) testing in maters class athletes. After&#xD;
      completing the informed consent and screening process (Visit #1), each participant will be&#xD;
      assessed for their anthropometric measures as well as body composition and will complete a&#xD;
      graded exercise test to volitional exhaustion on a cycle ergometer to determine VO2peak.&#xD;
      Forty-eight to 72 hours after Visit #1, or VO2peak testing, participants will return to the&#xD;
      lab for familiarization with the INT exercise protocol and TTE test (Visit #2). Within&#xD;
      forty-eight to 72 hours after familiarization (Visit #2), participants will return to the lab&#xD;
      for Visit #3 to complete INT exercise and TTE, a 2-hour passive recovery period including the&#xD;
      consumption of one of three treatments (CHO, CHO-P, PLA), followed by repeated INT exercise&#xD;
      and TTE, heart rate variability and sweat rate determination. Participants will also complete&#xD;
      the Nutritional Recovery Practices, Knowledge, and Beliefs of Australian Triathletes survey&#xD;
      during the 2-hour recovery period. Participants will be asked to complete the ASA24®, an&#xD;
      automated self-administered 24-hour dietary assessment tool during the 5-9-day period between&#xD;
      familiarization (Visit #2) and the experimental protocol (Visit #3).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to one of three groups: isocaloric carbohydrate (1.2 g/kg of body weight), carbohydrate-protein (0.8 g/kg body weight carbohydrate + 0.4 g/kg body weight protein), or placebo (flavored water). All three beverages will have a similar appearance and taste and participants will be blinded to the contents. All beverages will contain the same volume of fluid (1 liter).</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The primary investigator will not be blinded to the treatment groups. However, both the research assistants responsible for administering the experimental protocol (aerobic interval and time to exhaustion testing) and the participants will be.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Exhaustion (TTE)</measure>
    <time_frame>Visit #3 (Day 7)</time_frame>
    <description>Participants cycle for as long as possible at 90% of peak power output (watts)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (HRV)</measure>
    <time_frame>Visit #3 (Day 7)</time_frame>
    <description>R-R intervals recorded via a heart rate monitor and Elite HRV will be downloaded and analyzed using a laptop with commercially available HRV analysis software. Root mean square of the successive differences of R-R intervals (RMSSD) values will be recorded during the 90% TTE and then post-exercise every 5 min (end of TTE, 5min, 10min, 15min, 20min, 25min, 30min).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sweat Rate (SR)</measure>
    <time_frame>Visit #3 (Day 7)</time_frame>
    <description>Sweat rate will be determined based on the difference between pre-and post-weight changes for each bout of exercise, the amount of fluid consumed during the recovery period, and total exercise time in minutes.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Dietary Supplementations</condition>
  <arm_group>
    <arm_group_label>Carbohydrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Carbohydrate in the amount of 1.2 g/kg of body weight (bw). Gatorade®, Chicago, IL, USA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carbohydrate-Protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Carbohydrate in the amount of 0.8 g/kg bw (Gatorade®, Chicago, IL, USA) plus protein in the amount of 0.4 g/kg bw (biPro Elite, Agropur Inc., Appleton, WI, USA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Flavored water (G Zero, Gatorade®, Chicago, IL, USA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrate</intervention_name>
    <description>Participants have a one in three chance of consuming a carbohydrate beverage between two bouts of high-intensity exercise.</description>
    <arm_group_label>Carbohydrate</arm_group_label>
    <other_name>CHO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrate-Protein</intervention_name>
    <description>Participants have a one in three chance of consuming a carbohydrate-protein beverage between two bouts of high-intensity exercise.</description>
    <arm_group_label>Carbohydrate-Protein</arm_group_label>
    <other_name>CHO-P</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Participants have a one in three chance of consuming a placebo beverage between two bouts of high-intensity exercise.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>PLA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men between the ages of 35 and 59 years&#xD;
&#xD;
          -  Free of any physical limitations as determined by the Exercise Preparticipation Health&#xD;
             Screening Questionnaire for Exercise Professionals (PHSQEP), and a Physical Activity&#xD;
             Readiness Questionnaire for Everyone (PAR-Q+)&#xD;
&#xD;
          -  Regularly engaged in endurance exercise (running, cycling, swimming) for a minimum of&#xD;
             three years, a weekly training volume of 5-10 hours, and a maximal oxygen uptake of&#xD;
             45.00 ml·kg-1·min-1 or higher as determined by completion of VO2peak assessment (Visit&#xD;
             #1).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Recent musculoskeletal injuries or surgeries&#xD;
&#xD;
          -  Any chronic illness that requires continuous medical care&#xD;
&#xD;
          -  Current incarceration, cognitive impairment or inability to provide consent&#xD;
&#xD;
          -  Present or past use of performance-enhancing drugs&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Stout, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Central Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erica Goldstein, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Central Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erica Goldstein, MS</last_name>
    <phone>561-324-6955</phone>
    <email>egoldstein@knights.ucf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeffrey Stout, PhD</last_name>
    <phone>407.823.0211</phone>
    <email>Jeffrey.Stout@ucf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Central Florida</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica Graduate Research Associate</last_name>
      <phone>561-324-6955</phone>
      <email>egoldstein@knights.ucf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jeffrey Director School of Kinesiology and Physical Therapy</last_name>
      <phone>407.823.0211</phone>
      <email>Jeffrey.Stout@ucf.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>McCarthy DG, Spriet LL. Performance Effects of Carbohydrate Ingestion Between Bouts of Intense Aerobic Interval Exercise. Int J Sports Physiol Perform. 2020 Feb 1;15(2):262-267. doi: 10.1123/ijspp.2019-0239. Epub 2019 Jun 12.</citation>
    <PMID>31188694</PMID>
  </results_reference>
  <results_reference>
    <citation>Alghannam AF, Jedrzejewski D, Bilzon J, Thompson D, Tsintzas K, Betts JA. Influence of Post-Exercise Carbohydrate-Protein Ingestion on Muscle Glycogen Metabolism in Recovery and Subsequent Running Exercise. Int J Sport Nutr Exerc Metab. 2016 Dec;26(6):572-580. doi: 10.1123/ijsnem.2016-0021. Epub 2016 Aug 24.</citation>
    <PMID>27097042</PMID>
  </results_reference>
  <results_reference>
    <citation>Berardi JM, Price TB, Noreen EE, Lemon PW. Postexercise muscle glycogen recovery enhanced with a carbohydrate-protein supplement. Med Sci Sports Exerc. 2006 Jun;38(6):1106-13.</citation>
    <PMID>16775553</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Central Florida</investigator_affiliation>
    <investigator_full_name>Erica Goldstein</investigator_full_name>
    <investigator_title>Graduate Research Associate</investigator_title>
  </responsible_party>
  <keyword>glycogen</keyword>
  <keyword>glucose</keyword>
  <keyword>aerobic exercise</keyword>
  <keyword>time to exhaustion</keyword>
  <keyword>supplementation</keyword>
  <keyword>protein</keyword>
  <keyword>endurance</keyword>
  <keyword>recovery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT04859491/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT04859491/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

